You are currently viewing a new version of our website. To view the old version click .
Cancers | Highly Viewed Papers in 2024 and Hot Topic Special Issues on Cancer Drug Development

Cancers | Highly Viewed Papers in 2024 and Hot Topic Special Issues on Cancer Drug Development

7 February 2025


We are delighted to share some highly viewed papers on cancer drug development that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs”
by Virginia Metrangolo and Lars H. Engelholm
Cancers 2024, 16(2), 447; https://doi.org/10.3390/cancers16020447
Available online: https://www.mdpi.com/2072-6694/16/2/447

“Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer”
by Xin Gu and Tamara Minko
Cancers 2024, 16(8), 1589; https://doi.org/10.3390/cancers16081589
Available online: https://www.mdpi.com/2072-6694/16/8/1589

“Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989”
by Othman Al Musaimi
Cancers 2024, 16(5), 1032; https://doi.org/10.3390/cancers16051032
Available online: https://www.mdpi.com/2072-6694/16/5/1032

“Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review”
by Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, Mahima Bansode, Kratika Khunteta, Priyanka Vijay Sonar, Ameya Hebale, Vaishnavi Salokhe and Birandra Kumar Sinha
Cancers 2024, 16(4), 680; https://doi.org/10.3390/cancers16040680
Available online: https://www.mdpi.com/2072-6694/16/4/680

“Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma”
by Ali Al Sbihi, Maryam Alasfour and Georgios Pongas
Cancers 2024, 16(4), 827; https://doi.org/10.3390/cancers16040827
Available online: https://www.mdpi.com/2072-6694/16/4/827

“DDX3X and Stress Granules: Emerging Players in Cancer and Drug Resistance”
by Han Zhang, Paula M. Mañán-Mejías, Hannah N. Miles, Andrea A. Putnam, Leonard R. MacGillivray and William A. Ricke
Cancers 2024, 16(6), 1131; https://doi.org/10.3390/cancers16061131
Available online: https://www.mdpi.com/2072-6694/16/6/1131

Special Issues:

Drug Targeting Therapy in Multiple Myeloma
Guest Editors: Dr. Hiroshi Handa and Prof. Dr. Hideto Tamura
Submission deadline: 11 April 2025

Recent Advances in PROteolysis TArgeting Chimeras (PROTACs)
Guest Editors: Prof. Dr. Dhimant Desai and Dr. Mourad Zerfaoui
Submission deadline: 15 March 2025

 

 

Understanding the Complexities of Anticancer Drugs Resistance
Guest Editors: Dr. Mariarosaria Conte and Dr. Nunzio Del Gaudio
Submission deadline: 30 May 2025

Drug Repurposing and Reformulation for Cancer Treatment: 2nd Edition
Guest Editors: Dr. Arati Sharma, Prof. Dr. Dhimant Desai and Dr. Abhijit Date
Submission deadline: 15 June 2025

 

 

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office